tirzepatide ban update WADA just added (mounjaro) to the 2026 Monitoring Program FDA confirms tirzepatide shortage is

Learn More at En Vogue IV Therapy and Wellness in Southampton PA.

Reduce hair fall by 30% in two months, and stimulate hair follicle growth by 200%

Comorbidities and pathomechanisms that lead to additional increases in cardiac filling pressures accelerate the age-related deterioration in diastolic function

In just a few years, Hims and Hers Health Inc

Rhode Island's Medicaid agency proposes ending GLP-1 coverage for weight loss while keeping diabetes uses, citing soaring costs.

The first biosimilar formulation of a GLP-1 receptor agonist, liraglutide, has recently been marketed, at a lower acquisition cost than the original formulation, whilst oral semaglutide remains the only currently available GLP-1 receptor agonist that is administered orally